Fulgent Genetics (FLGT)
(Delayed Data from NSDQ)
$25.06 USD
+1.49 (6.32%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $25.02 -0.04 (-0.16%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
FLGT 25.06 +1.49(6.32%)
Will FLGT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for FLGT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FLGT
Fulgent Genetics, Inc. (FLGT) Beats Q2 Earnings and Revenue Estimates
Fulgent Genetics (FLGT) Soars 6.6%: Is Further Upside Left in the Stock?
FLGT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates
American Well Corporation (AMWL) Reports Q1 Loss, Misses Revenue Estimates
Privia Health (PRVA) Misses Q4 Earnings Estimates
Other News for FLGT
Fulgent Genetics, Inc. (FLGT) Q2 2024 Earnings Call Transcript
Fulgent Reports Second Quarter 2024 Financial Results
Fulgent Genetics Inc (FLGT) Q2 2024 Earnings: EPS of ($0.29) Beats Estimates, Revenue of $71. ...
Fulgent Genetics Releases Updated Investor Presentation
Fulgent Genetics raises FY24 EPS view to (30c) from ($1.05), consensus (92c)